Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
Listen now
Description
Dr Nastoupil and Dr Dreyling discuss PI3K inhibition in follicular lymphoma, including practical considerations and treatment selection. Credit available for this activity expires: 6/7/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952387?src=mkm_podcast_addon_952387
More Episodes
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer? Credit available for this activity expires: 4/16/25 Earn Credit / Learning Objectives & Disclosures:...
Published 04/17/24
Who in the care team can detect cognitive impairment and aid in diagnosing early stages of Alzheimer's disease (AD)? Credit available for this activity expires: 4/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000668?ecd=bdc_podcast_libsyn_mscpedu
Published 04/12/24
Published 04/12/24